ride for BPH. Tadalafil/Finasteride is another asset that Veru is developing for treatment of BPH and would utilize 505(b)(2) pathway for approval. Tadalafil and Finasteride are both used for BPH besides several other disease/disorder conditions. Tadalafil manufactured by Eli Lilly is marketed as Cialis

d 2018), Solifenacin DRG, slow release granules, for overactive bladder (urge incontinence, urgency and frequency of urination) (NDA planned 2019), Tadalafil/finasteride combination tablet for restricted urination because of an enlarged prostate (NDA planned 2019), VERU-944 (cis-clomiphene citrate) for ho